PLoS ONE · 2014 · 82 citations · 19 references
Non- and micro-invasive treatments have lower long-term costs than invasive therapy of proximal lesions. Micro-invasive therapy had the highest cost-effectiveness for treating D1 lesions in young patients. Decision makers with a willingness-to-pay over 16.73 € and 1.57 € for E2 and D1 lesions, respectively, will find micro-invasive treatment more cost-effective than non-invasive therapy.
19
Aaron A. Stinnett, John Mullahy · Medical Decision Making · 1998 · 1.1K citations
Carrier Screening for Cystic Fibrosis
David A. Asch, John C. Hershey, Michael L. DeKay et al. · Medical Decision Making · 1998 · 374 citations